Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma. | UCSF Helen Diller Family Comprehensive Cancer Center

Author List

Pan E, Supko JG, Kaley TJ, Butowski NA, Cloughesy T, Jung J, Desideri S, Grossman S, Ye X, Park DM

Publication

Journal of neuro-oncology

Publication ID (Profile URL)

https://researcherprofiles.org/profile/1206067

Publication Year

2016

PubMed ID

27826680

Publication Title

Pan E, Supko JG, Kaley TJ, Butowski NA, Cloughesy T, Jung J, Desideri S, Grossman S, Ye X, Park DM. Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma. J Neurooncol. 2016 12; 130(3):571-579.